S&P Futures
4,271.50 -9.50 (-0.22%) Dow Futures
33,648.00 -70.00 (-0.21%) Nasdaq Futures
13,544.00 -33.75 (-0.25%) Russell 2000 Futures
2,011.50 -5.40 (-0.27%) Crude Oil
91.20 -0.89 (-0.97%) Gold
1,809.30 -6.20 (-0.34%)
Arcadia Biosciences, Inc. (RKDA)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.9500 |
| Open | 0.9900 |
| Bid | 0.0000 x 2200 |
| Ask | 0.0000 x 1300 |
| Day's Range | 0.9702 - 1.0982 |
| 52 Week Range | 0.7400 - 2.6700 |
| Volume | |
| Avg. Volume | 309,793 |
| Market Cap | 23.747M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9600 |
| Earnings Date | Nov 14, 2022 - Nov 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.75 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for RKDA
Related Research
- Arcadia Biosciences, Inc.Analyst Report: DuPont de Nemours IncDuPont de Nemours Inc. is a leading specialty chemicals company, formerly known as DowDuPont Inc., and operates through two business segments: Electronics & Industrial and Water & Protection. The Electronics & Industrial segment supplies materials and printing systems to the advanced printing industry and materials and solutions for the fabrication of semiconductors and integrated circuits. The Water & Protection segment provides engineered products and integrated systems for worker safety, water purification and separation, transportation, energy, medical packaging, and building materials.RatingFair ValueEconomic Moat3 days agoArgus Research
- PR Newswire
Arcadia Biosciences (RKDA) Announces $5.0 Million Registered Direct Offering Priced At-The-Market
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that it has entered into securities purchase agreements with a single healthcare-focused institutional investor for the purchase and sale of 4,722,506 shares of its common stock (or common stock equivalents) at a purchase price of $1.05876 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the company agreed to is
- PR Newswire
Arcadia Biosciences (RKDA) Announces Strong Second-Quarter and First-Half 2022 Financial Results and Business Highlights
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2022.
- PR Newswire
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2022 after market close on August 11, 2022.
